Correlation Between Auxly Cannabis and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Auxly Cannabis and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Auxly Cannabis and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Auxly Cannabis Group and Medipharm Labs Corp, you can compare the effects of market volatilities on Auxly Cannabis and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Auxly Cannabis with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Auxly Cannabis and Medipharm Labs.

Diversification Opportunities for Auxly Cannabis and Medipharm Labs

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Auxly and Medipharm is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Auxly Cannabis Group and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Auxly Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Auxly Cannabis Group are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Auxly Cannabis i.e., Auxly Cannabis and Medipharm Labs go up and down completely randomly.

Pair Corralation between Auxly Cannabis and Medipharm Labs

Assuming the 90 days trading horizon Auxly Cannabis Group is expected to generate 1.63 times more return on investment than Medipharm Labs. However, Auxly Cannabis is 1.63 times more volatile than Medipharm Labs Corp. It trades about 0.01 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about -0.09 per unit of risk. If you would invest  4.00  in Auxly Cannabis Group on August 30, 2024 and sell it today you would lose (0.25) from holding Auxly Cannabis Group or give up 6.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Auxly Cannabis Group  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
Auxly Cannabis Group 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Auxly Cannabis Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Auxly Cannabis may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Medipharm Labs is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Auxly Cannabis and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Auxly Cannabis and Medipharm Labs

The main advantage of trading using opposite Auxly Cannabis and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Auxly Cannabis position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind Auxly Cannabis Group and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Transaction History
View history of all your transactions and understand their impact on performance